Receptors, IgG

"Receptors, IgG" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor).

Descriptor ID	D017452
MeSH Number(s)	D12.776.543.750.705.871.300
Concept/Terms	Receptors, IgG Receptors, IgG IgG Receptors gamma Fc Receptors Fc gamma Receptors gamma Receptors, Fc Receptors, Fc gamma Immunoglobulin G Receptor Receptor, Immunoglobulin G Fc Receptors, gamma Receptors, gamma Fc CD32 Antigens CD32 Antigens CD 32 Antigens Antigens, CD 32 Fc gamma RII gamma RII, Fc Antigens, CD32 Leu-11 Antigens Leu-11 Antigens Antigens, Leu-11 Leu 11 Antigens CD64 Antigens CD64 Antigens CD 64 Antigens Antigens, CD 64 Fc gamma RI gamma RI, Fc Antigens, CD64 Antigens, CD16 Antigens, CD16 Fc gamma RIII gamma RIII, Fc CD 16 Antigens Antigens, CD 16 CD16 Antigens CDw32 Antigens CDw32 Antigens Antigens, CDw32

Below are MeSH descriptors whose meaning is more general than "Receptors, IgG".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, Immunologic [D12.776.543.750.705]
Receptors, Fc [D12.776.543.750.705.871]
Receptors, IgG [D12.776.543.750.705.871.300]

Below are MeSH descriptors whose meaning is related to "Receptors, IgG".

Below are MeSH descriptors whose meaning is more specific than "Receptors, IgG".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, IgG" by people in this website by year, and whether "Receptors, IgG" was a major or minor topic of these publications.

Bar chart showing 42 publications over 22 distinct years, with a maximum of 4 publications in 2005 and 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	2	0	2
1994	2	0	2
1995	1	0	1
1996	2	0	2
1998	1	1	2
1999	1	0	1
2000	1	0	1
2002	1	0	1
2003	0	3	3
2004	0	2	2
2005	3	1	4
2006	2	1	3
2007	2	2	4
2008	1	0	1
2009	1	1	2
2010	0	3	3
2011	0	1	1
2012	1	1	2
2015	1	0	1
2016	1	0	1
2018	0	2	2
2022	0	1	1

Below are the most recent publications written about "Receptors, IgG" by people in Profiles.

Campana S, De Pasquale C, Sidoti Migliore G, Pezzino G, Cavaliere R, Venanzi Rullo E, Nunnari G, Caramori G, David A, Bonaccorsi I, Pollicino T, Carrega P, Ferlazzo G. Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients. J Immunol. 2022 08 15; 209(4):655-659.

View in: PubMed
Campbell KS, Cohen AD, Pazina T. Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma. Front Immunol. 2018; 9:2551.

View in: PubMed
Tomalka AG, Resto-Garay I, Campbell KS, Popkin DL. In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells. Front Immunol. 2018; 9:2552.

View in: PubMed
Jochems C, Hodge JW, Fantini M, Fujii R, Morillon YM, Greiner JW, Padget MR, Tritsch SR, Tsang KY, Campbell KS, Klingemann H, Boissel L, Rabizadeh S, Soon-Shiong P, Schlom J. An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele. Oncotarget. 2016 Dec 27; 7(52):86359-86373.

View in: PubMed
Soni C, Domeier PP, Wong EB, Khan TN, Elias MJ, Schell SL, Lukacher AE, Cooper TK, Rahman ZS. Distinct and synergistic roles of Fc?RIIB deficiency and 129 strain-derived SLAM family proteins in the development of spontaneous germinal centers and autoimmunity. J Autoimmun. 2015 Sep; 63:31-46.

View in: PubMed
Grier JT, Forbes LR, Monaco-Shawver L, Oshinsky J, Atkinson TP, Moody C, Pandey R, Campbell KS, Orange JS. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. J Clin Invest. 2012 Oct; 122(10):3769-80.

View in: PubMed
Trotta R, Chen L, Ciarlariello D, Josyula S, Mao C, Costinean S, Yu L, Butchar JP, Tridandapani S, Croce CM, Caligiuri MA. miR-155 regulates IFN-? production in natural killer cells. Blood. 2012 Apr 12; 119(15):3478-85.

View in: PubMed
Stolla M, Stefanini L, André P, Ouellette TD, Reilly MP, McKenzie SE, Bergmeier W. CalDAG-GEFI deficiency protects mice in a novel model of Fc? RIIA-mediated thrombosis and thrombocytopenia. Blood. 2011 Jul 28; 118(4):1113-20.

View in: PubMed
Baiocchi RA, Alinari L, Lustberg ME, Lin TS, Porcu P, Li X, Johnston JS, Byrd JC, Blum KA. Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma. Cancer. 2011 Jun 01; 117(11):2442-51.

View in: PubMed
Reilly MP, Sinha U, André P, Taylor SM, Pak Y, Deguzman FR, Nanda N, Pandey A, Stolla M, Bergmeier W, McKenzie SE. PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model. Blood. 2011 Feb 17; 117(7):2241-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement